News
07-31-2019, 11:40 PM
OTraces, Inc., a molecular diagnostics company specializing in early cancer detection, has announced completion of a preliminary study for detection of pancreatic cancer.
More... (https://www.news-medical.net/news/20190801/Preliminary-study-for-detection-of-pancreatic-cancer-shows-encouraging-results.aspx)
More... (https://www.news-medical.net/news/20190801/Preliminary-study-for-detection-of-pancreatic-cancer-shows-encouraging-results.aspx)